RecruitingNCT03805919
40
studies recruiting now
as of 7 Sept 2026
151
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
17 Feb 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT07194551
Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire
RecruitingNCT05410977
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
RecruitingPhase 1 / Phase 2NCT07411599
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
RecruitingNot applicableNCT07106359
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 40 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Lynch syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Lynch syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (MSH6, KRAS, PMS1, TGFBR2, MSH2, EPCAM).
Treatments being studied
3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Aspirin (8-hour bayer)
Phase 2Icosapent
Phase 1Naproxen (Arthrosin 250)
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).